HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 4.64
Day range
kr 4.64 - kr 4.78
Year range
kr 3.03 - kr 7.67
Market cap
1.85B SEK
Avg Volume
2.15M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 17.40M | 85.11% |
Operating expense | 80.10M | -7.61% |
Net income | -82.40M | 4.41% |
Net profit margin | -473.56 | 48.36% |
Earnings per share | -0.20 | 33.33% |
EBITDA | -66.50M | 17.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 145.70M | 12.16% |
Total assets | 595.10M | 3.05% |
Total liabilities | 317.60M | 22.67% |
Total equity | 277.50M | — |
Shares outstanding | 359.24M | — |
Price to book | 6.02 | — |
Return on assets | -30.65% | — |
Return on capital | -46.63% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -82.40M | 4.41% |
Cash from operations | -49.10M | 21.44% |
Cash from investing | — | — |
Cash from financing | -8.20M | -1,266.67% |
Net change in cash | -56.90M | 9.25% |
Free cash flow | -28.94M | 29.70% |
About
Founded
2006
Website
Employees
40
